Full Text View
Tabular View
No Study Results Posted
Related Studies
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
This study is ongoing, but not recruiting participants.
Study NCT00931528   Information provided by National Cancer Institute (NCI)

First Received on June 30, 2009.   Last Updated on February 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Sexual Dysfunction
Additional conditions recognized in this trial
Erectile Dysfunction
Prostatic Neoplasms
Sexual Dysfunctions, Psychological
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Mental Disorders
Neoplasms
Neoplasms by Site
Prostatic Diseases
Sexual and Gender Disorders
Sexual Dysfunction, Physiological
Urogenital Neoplasms
Interventions listed in this trial
tadalafil
placebo
Additional drug interventions recognized in this trial
Phosphodiesterase 5 Inhibitors
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Radiation Therapy Oncology Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services